Michael Adam Bell is Director of Syneos Health, Inc.. Currently has a direct ownership of 4,103 shares of SYNH, which is worth approximately $0. The most recent transaction as insider was on May 24, 2018, when has been sold 4,103 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.1K
0% 3M change
0% 12M change
Total Value Held $0

Michael Adam Bell Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 24 2018
BUY
Grant, award, or other acquisition
-
4,103 Added 50.0%
4,103 Class A Common Stock
Feb 27 2018
SELL
Bona fide gift
-
109,316 Reduced 100.0%
0 Class A Common Stock
Aug 01 2017
SELL
Payment of exercise price or tax liability
$939,509 $55.85 p/Share
16,822 Reduced 13.34%
109,316 Class A Common Stock
MAB

Michael Adam Bell

Director
Raleigh, NC

Track Institutional and Insider Activities on SYNH

Follow Syneos Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYNH shares.

Notify only if

Insider Trading

Get notified when an Syneos Health, Inc. insider buys or sells SYNH shares.

Notify only if

News

Receive news related to Syneos Health, Inc.

Track Activities on SYNH